Here is a list of all published ProgStar study reports.
We do our best to regularly update this list.
More relevant articles and publications can be found in section Publications of this website.
ProgStar study results – video (with ppt slides) summary
The following video is a presentation given by HPN Scholl at the ISGEDR 2019 Joint Meeting with DOG at Giessen, which included a summary of the main ProgStar study results:
ProgStar study report publications
Faster Sensitivity Loss Around Dense Scotomas Than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14
Am J Ophthalmol. 2020 Mar 25;S0002-9394(20)30120-3.
doi: 10.1016/j.ajo.2020.03.020.
Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months. ProgStar Report No. 13
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period. ProgStar Report No. 11
JAMA Ophthalmology, published online August 1, 2019.
doi:10.1001/jamaophthalmol.2019.2885
Visual Acuity Change over 24 Months and its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease. ProgStar Report Number 10
PROGRESSION OF STARGARDT DISEASE AS DETERMINED BY FUNDUS AUTOFLUORESCENCE IN THE RETROSPECTIVE PROGRESSION OF STARGARDT DISEASE STUDY (PROGSTAR REPORT NO. 9)
MACULAR SENSITIVITY MEASURED WITH MICROPERIMETRY IN STARGARDT DISEASE IN THE PROGRESSION OF ATROPHY SECONDARY TO STARGARDT DISEASE (PROGSTAR) STUDYREPORT NO. 7
JAMA Ophthalmol. Published online May 25, 2017. doi:10.1001/jamaophthalmol.2017.1162
VISUAL ACUITY CHANGE OVER 12 MONTHS IN THE PROSPECTIVE PROGRESSION OF ATROPHY SECONDARY TO STARGARDT DISEASE (PROGSTAR) STUDY: PROGSTAR REPORT NUMBER 6
Ophthalmology. 2017 May 23. pii: S0161-6420(17)30607-3. doi: 10.1016/j.ophtha.2017.04.026. [Epub ahead of print]
INCIDENCE OF ATROPHIC LESIONS IN STARGARDT DISEASE IN THE PROGRESSION OF ATROPHY SECONDARY TO STARGARDT DISEASE (PROGSTAR) STUDYREPORT NO. 5
JAMA Ophthalmol. Published online May 25, 2017. doi:10.1001/jamaophthalmol.2017.1121
PROGRESSION OF VISUAL ACUITY AND FUNDUS AUTOFLUORESCENCE IN RECENT-ONSET STARGARDT DISEASE: PROGSTAR STUDY REPORT #4
Ophthalmology Retina, Available online 28 April 2017, ISSN 2468-6530,
https://doi.org/10.1016/j.oret.2017.02.008
FIXATION LOCATION AND STABILITY USING THE MP-1 MICROPERIMETER IN STARGARDT DISEASE : PROGSTAR REPORT NO. 3
Ophthalmology Retina. 2017 Jan-Feb;1(1):68-76
VISUAL ACUITY LOSS AND ASSOCIATED RISK FACTORS IN THE RETROSPECTIVE PROGRESSION OF STARGARDT DISEASE STUDY (PROGSTAR REPORT NO. 2)
Opthalmology 2016, Sep; 123(9): 1887-97. doi: 10.1016/j.ophtha.2016.05.027. Epub 2016 Jul 2
THE NATURAL HISTORY OF THE PROGRESSION OF ATROPHY SECONDARY TO STARGARDT DISEASE (PROGSTAR) STUDIES: DESIGN AND BASELINE CHARACTERISTICS: PROGSTAR REPORT NO. 1
Ophthalmology 2016, Jan 16. pii: S0161-6420(15)01433-5. doi: 10.1016/j.ophtha.2015.12.009. [Epub ahead of print] PMID: 26786511